Two studies of meningococcal carriage state were carried out in Galicia (Spain) before and after a mass vaccination campaign between December 1996 and January 1997 against Neisseria meningitidis serogroup C with meningococcal serogroups A and C polysaccharide vaccine. The studies covered two areas with different incidence rates of meningococcal disease in 1996 (high and low incidence). Carriage rates of serogroup C showed a decrease in both areas, 47 and 65 % respectively, before and after the vaccination. Results showed a decrease in carrier state in the age groups 10-14-and 15-19-year-olds, but not in the 5-9-year-olds. These results demonstrate the effect of immunization on the reduction of the carriage state.
INTRODUCTIONIn Galicia, a region situated in north-west Spain (population, 2·7 million), meningococcal disease is an endemic disease. During the early part of the 1990s, the approximate incidence rate of meningococcal disease was three cases per 100 000 population, but by 1995/1996, the incidence had risen sharply to 11 cases per 100 000 population. Unlike previous years, when Neisseria meningitidis serogroup B was the most frequently isolated serogroup, the increased incidence registered in 1995/1996 was caused by N. meningitidis serogroup C (Direcció n Xeral de Saú de, 1995). Faced with this situation, the Galician Regional Public Health Authorities looked into different disease prevention and control measures, and eventually decided to conduct a N. meningitidis C vaccination campaign, using meningococcal group A and C polysaccharide vaccine and targeting all residents in Galicia aged 18 months to 19 years. The campaign was carried out in the period December 1996-January 1997, with a total of 472 465 vaccinated persons.In the wake of the vaccination campaign, a marked decline in the incidence of meningococcal disease was observed. By 1998, 1 year after vaccination, the incidence rate had declined from a pre-vaccination figure of 10·42 to 4·3 cases per 100 000 population (Direcció n Xeral de Saú de, 1998). At this time, it was decided that, in view of the importance of healthy carriers in the epidemiology of meningococcal disease (Broome, 1986), a study should be undertaken immediately prior to vaccination, aimed at ascertaining the incidence of carriers of N. meningitidis C : 2b : P1.2.5 -the strain most frequently isolated during the epidemic period -and studying the relationship between carriage and incidence of meningococcal disease (Fernández et al., 1999). For study purposes, two areas that registered different meningococcal disease incidence were therefore demarcated.In 1998, 1 year after the vaccination campaign, a new N. meningitidis C carriage study was carried out, with the aim of determining any possible differences in carriage prevalence before and after vaccination with meningococcal group A and C polysaccharide vaccine. This paper reports the differences between the above two studies, which covered the segment of the population aged 5-19 years.
METHODSPopulation and selection of sample. ...